However, these patients often experience increased treatment challenges and poor prognosis, indicating that the immune infiltration associated with high LACTB expression may promote tumor progression in pancreatic adenocarcinoma (Figure 3) [43]. The gene discussed is LACTB; the disease is pancreatic adenocarcinoma.